594P The efficacy of anti-EGFR therapy for RAS mutant metastatic colorectal cancer (mCRC) patients with RAS mutation negative in circulating-tumor DNA (ctDNA) after 1st- or 2nd-line chemotherapyN. Izawa, Yu Sunakawa, Wataru Ichikawa et al.|Annals of Oncology|2023Cited by 1